BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37611825)

  • 1. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.
    Zhang Y; Wan X; Yang X; Liu X; Huang Q; Zhou L; Zhang S; Liu S; Xiong Q; Wei M; Qiu L; Zhang B; Han J
    J Biol Chem; 2023 Sep; 299(9):105177. PubMed ID: 37611825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.
    Yuan Y; Zhang Y; Yao S; Shi H; Huang X; Li Y; Wei Y; Lin S
    J Biol Chem; 2014 Oct; 289(41):28310-23. PubMed ID: 25147179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
    Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
    Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.
    Zhang Y; Wang P; Zhang Q; Yao X; Zhao L; Liu Y; Liu X; Tao R; Yu C; Li Y; Song X; Yao S
    Oncotarget; 2017 Mar; 8(12):19968-19979. PubMed ID: 28193911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3-mediated m
    Li B; Xiong X; Xu J; Peng D; Nie G; Wen N; Wang Y; Lu J
    Oncogene; 2024 Mar; 43(14):1050-1062. PubMed ID: 38374407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
    Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
    Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
    J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
    Yoshino H; Enokida H; Osako Y; Nohata N; Yonemori M; Sugita S; Kuroshima K; Tsuruda M; Tatarano S; Nakagawa M
    Mol Oncol; 2020 Sep; 14(9):2190-2202. PubMed ID: 32386122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth.
    Chen J; Chung F; Yang G; Pu M; Gao H; Jiang W; Yin H; Capka V; Kasibhatla S; Laffitte B; Jaeger S; Pagliarini R; Chen Y; Zhou W
    Oncotarget; 2013 Dec; 4(12):2502-11. PubMed ID: 24318446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism.
    Shu Y; Hao Y; Feng J; Liu H; Li ST; Feng J; Jiang Z; Ye L; Zhou Y; Sun Y; Zhou Z; Wei H; Gao P; Zhang H; Sun L
    EMBO J; 2022 Dec; 41(23):e111550. PubMed ID: 36314841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA N
    Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
    Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.
    Ahlemann M; Zeidler R; Lang S; Mack B; Münz M; Gires O
    Mol Carcinog; 2006 Dec; 45(12):957-67. PubMed ID: 16929481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.
    Luo W; Zou Z; Nie Y; Luo J; Ming Z; Hu X; Luo T; Ouyang M; Liu M; Tang H; Xie Y; Peng K; Chen L; Zhou J; Luo Z
    Cell Death Dis; 2024 May; 15(5):319. PubMed ID: 38710705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
    Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
    Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
    Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Phosphoglycerate dehydrogenase expression is regulated by HOXA10 in murine endometrium and human endometrial cells.
    Du H; Vitiello D; Sarno JL; Taylor HS
    Reproduction; 2010 Jan; 139(1):237-45. PubMed ID: 19778996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.
    Dong JK; Lei HM; Liang Q; Tang YB; Zhou Y; Wang Y; Zhang S; Li WB; Tong Y; Zhuang G; Zhang L; Chen HZ; Zhu L; Shen Y
    Theranostics; 2018; 8(7):1808-1823. PubMed ID: 29556358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.